Aurora Spine: Showcasing Innovations at NASS 2024

Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, has announced its participation at the 2024 North American Spine Society ("NASS") Annual Meeting. This event, taking place from September 25-28, 2024, at McCormick Place, West Building, in Chicago, Illinois, provides a unique platform for Aurora Spine to showcase its latest innovations and network with key players in the spine industry.


Aurora Spine will be exhibiting at Booth #4510, where it will feature several cutting-edge products designed to transform spinal surgery. The SiLO™ TFX SI Fusion System for sacroiliac joint fusion surgery and the DEXA-C cervical interbody cage system, powered by Aurora's patented DEXA™ Technology, will be among the highlights. This technology offers patient-matched implants designed to align with individual bone density and T-Score, ushering in a new era of personalized spinal care.


Additionally, Aurora Spine will showcase the new Hydra™ and OSTEO-ONYX™ lumbar fusion systems, promoting Rough Surface Technology (RST), and its ZIP-51® Interlaminar Fusion System, which enables minimally invasive L5/S1 fusion without screws, improving procedural efficiency and patient recovery.




Aurora Spine's participation in NASS 2024 is expected to enhance its networking opportunities with key players in the spine industry, further solidifying its position as a leader in the development of groundbreaking medical devices for spinal surgery. The showcase of its latest innovations, such as the SiLO™ TFX SI Fusion System and DEXA-C cervical interbody cage system, is likely to influence its market reputation and potential sales, as surgeons and institutions seek out the most advanced and effective solutions for their patients.


Strategic partnerships or collaborations formed at NASS 2024 could significantly impact Aurora Spine's future growth and product development. By working with thought-leading spine surgeons and institutions, Aurora Spine can gain valuable insights and guidance to bring life-changing technology to patients in need.




In conclusion, Aurora Spine's participation in NASS 2024 is a testament to its commitment to innovation and leadership in the spinal implant market. By showcasing its latest innovations and fostering strategic partnerships, Aurora Spine continues to position itself as a driving force in the development of groundbreaking medical devices for spinal surgery.